Previous close | 0.2500 |
Open | 0.2500 |
Bid | 0.0000 |
Ask | 0.4500 |
Strike | 9.00 |
Expiry date | 2024-10-18 |
Day's range | 0.2500 - 0.2500 |
Contract range | N/A |
Volume | |
Open interest | 1.72k |
Key Insights C4 Therapeutics will host its Annual General Meeting on 20th of June Salary of US$639.0k is part of CEO...
Cooper Brings Decades of Global Pharmaceutical and Biotechnology Leadership Experience Bruce Downey Remains a Member of the Board of Directors and Chair of the Organization, Leadership and Compensation Committee Transition Further Highlights Commitment to Strategically Transform the Board to Lead C4T into Next Phase of Growth WATERTOWN, Mass., June 10, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted p
Just because a business does not make any money, does not mean that the stock will go down. For example, although...